Gts Securities LLC Senseonics Holdings, Inc. Call Options Transaction History

Gts Securities LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 13, 2024	SELL	$0.32 - $0.49 $800 - $1,225	-2,500 Reduced 2.75%	88,500 $30,000
Q2 2024 Aug 14, 2024	SELL	$0.37 - $0.52 $4,514 - $6,344	-12,200 Reduced 11.82%	91,000 $36,000
Q1 2024 May 15, 2024	SELL	$0.5 - $0.73 $35,150 - $51,319	-70,300 Reduced 40.52%	103,200 $54,000
Q4 2023 Feb 14, 2024	SELL	$0.48 - $0.7 $6,576 - $9,590	-13,700 Reduced 7.32%	173,500 $98,000
Q3 2023 Nov 15, 2023	BUY	$0.5 - $1.05 $93,600 - $196,560	187,200 New	187,200 $112,000

142

59.9M

393K

254K

Ticker SENS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 465,447,008
Market Cap $130M
Description
Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Gts Securities LLC with notifications on news.